Antithrombotic treatment in atrial fibrillation patients needing percutaneous coronary intervention
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1876-6250
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Antithrombotic treatment in atrial fibrillation patients needing percutaneous coronary intervention ; volume:29 ; number:3 ; day:10 ; month:2 ; year:2021 ; pages:119-120 ; date:3.2021
Netherlands heart journal ; 29, Heft 3 (10.2.2021), 119-120, 3.2021
- Urheber
-
Huisman, M. V.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s12471-021-01546-x
- URN
-
urn:nbn:de:101:1-2021041123305591573271
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:00 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Huisman, M. V.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Antithrombotic therapy in coronary artery disease patients with atrial fibrillation
Antithrombotic therapy in patients with atrial fibrillation and coronary artery disease
Optimal antithrombotic treatment of patients with atrial fibrillation undergoing percutaneous coronary intervention: triple therapy is too much!
The WOEST 2 registry : A prospective registry on antithrombotic therapy in atrial fibrillation patients undergoing percutaneous coronary intervention
How cardiologists manage antithrombotic treatment of patients with atrial fibrillation undergoing percutaneous coronary stenting: the WOEST survey 2018
Left atrial appendage closure in nonvalvular atrial fibrillation patients with percutaneous coronary intervention
Platelet function testing in atrial fibrillation patients undergoing percutaneous coronary intervention
Bleeding risk factors and real-world antithrombotic therapies in elderly patients with atrial fibrillation undergoing percutaneous coronary intervention: a retrospective study
Safety and efficacy of dual versus triple antithrombotic therapy in Patients with atrial fibrillation undergoing percutaneous coronary intervention: a meta-analysis
Clinical impact of high platelet reactivity in patients with atrial fibrillation and concomitant percutaneous coronary intervention on dual or triple antithrombotic therapy
Dual Antithrombotic Therapy with Clopidogrel and Novel Oral Anticoagulants in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Real-world Study
Dual-pathway antithrombotic therapy in patients with atrial fibrillation after percutaneous coronary intervention in stable coronary artery disease: a single-center, single-operator, retrospective cohort study
Antithrombotic therapy in coronary artery disease patients with atrial fibrillation
Antithrombotic therapy in patients with atrial fibrillation and coronary artery disease
Optimal antithrombotic treatment of patients with atrial fibrillation undergoing percutaneous coronary intervention: triple therapy is too much!
The WOEST 2 registry : A prospective registry on antithrombotic therapy in atrial fibrillation patients undergoing percutaneous coronary intervention
How cardiologists manage antithrombotic treatment of patients with atrial fibrillation undergoing percutaneous coronary stenting: the WOEST survey 2018
Left atrial appendage closure in nonvalvular atrial fibrillation patients with percutaneous coronary intervention
Platelet function testing in atrial fibrillation patients undergoing percutaneous coronary intervention
Bleeding risk factors and real-world antithrombotic therapies in elderly patients with atrial fibrillation undergoing percutaneous coronary intervention: a retrospective study
Safety and efficacy of dual versus triple antithrombotic therapy in Patients with atrial fibrillation undergoing percutaneous coronary intervention: a meta-analysis
Clinical impact of high platelet reactivity in patients with atrial fibrillation and concomitant percutaneous coronary intervention on dual or triple antithrombotic therapy
Dual Antithrombotic Therapy with Clopidogrel and Novel Oral Anticoagulants in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Real-world Study
Dual-pathway antithrombotic therapy in patients with atrial fibrillation after percutaneous coronary intervention in stable coronary artery disease: a single-center, single-operator, retrospective cohort study
Antithrombotic therapy in coronary artery disease patients with atrial fibrillation
Antithrombotic therapy in patients with atrial fibrillation and coronary artery disease
Optimal antithrombotic treatment of patients with atrial fibrillation undergoing percutaneous coronary intervention: triple therapy is too much!
The WOEST 2 registry : A prospective registry on antithrombotic therapy in atrial fibrillation patients undergoing percutaneous coronary intervention
How cardiologists manage antithrombotic treatment of patients with atrial fibrillation undergoing percutaneous coronary stenting: the WOEST survey 2018
Left atrial appendage closure in nonvalvular atrial fibrillation patients with percutaneous coronary intervention
Platelet function testing in atrial fibrillation patients undergoing percutaneous coronary intervention
Bleeding risk factors and real-world antithrombotic therapies in elderly patients with atrial fibrillation undergoing percutaneous coronary intervention: a retrospective study
Safety and efficacy of dual versus triple antithrombotic therapy in Patients with atrial fibrillation undergoing percutaneous coronary intervention: a meta-analysis
Clinical impact of high platelet reactivity in patients with atrial fibrillation and concomitant percutaneous coronary intervention on dual or triple antithrombotic therapy
Dual Antithrombotic Therapy with Clopidogrel and Novel Oral Anticoagulants in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Real-world Study